Bruce Cozadd, Jazz CEO (Jazz Pharmaceuticals)
Jazz CEO Bruce Cozadd campaigned for 6 months to buy GW Pharma. A 90% premium sealed the deal — along with $17.6M in ‘retention’ incentives
Jazz CEO Bruce Cozadd didn’t beat around the bush.
In his first video meeting with GW Pharma chief Justin Gover last July 8, he offered …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
